Trials / Unknown
UnknownNCT01720030
Levosimendan in Acute Kidney Injury Study
Prospective, Randomized, Monocenter, Double Blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Levosimendan in Intensive Care Patients With Acute Kidney Injury
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- VieCuri Medical Centre · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We hypothesise that levosimendan will have a positive influence on renal function during acute kidney injury in adult intensive care patients.
Detailed description
The purpose of this trial is to evaluate whether the use of levosimendan is able to improve renal function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levosimendan | Verum therapy |
| DRUG | Conventional therapy | Placebo therapy to safeguard blinding |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-10-01
- Completion
- 2017-10-01
- First posted
- 2012-11-01
- Last updated
- 2016-09-27
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01720030. Inclusion in this directory is not an endorsement.